The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis

(1–3)-Beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients

(2014) F. Esteves et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients

(2014) A. Roux et al.   MEDECINE ET MALADIES INFECTIEUSES

Pneumocystis jirovecii pneumonia in HIV-negative patients: A prospective study with focus on immunosuppressive drugs and markers of immune impairment

(2014) France Roblot et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors

(2013) S. Neumann et al.   ANNALS OF HEMATOLOGY

Trimethoprim Resistance of Dihydrofolate Reductase Variants from Clinical Isolates of Pneumocystis jirovecii

(2013) S. F. Queener et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology Linking Multihospital Clusters of Opportunistic Pneumocystis jirovecii Pneumonia

(2013) B. J. Nankivell et al.   CLINICAL INFECTIOUS DISEASES

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients

(2013) M. Maillet et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Combined Quantification of Pulmonary Pneumocystis jirovecii DNA and Serum (1->3)- -D-Glucan for Differential Diagnosis of Pneumocystis Pneumonia and Pneumocystis Colonization

(2013) C. Damiani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pneumocystis polymerase chain reaction and blood (1→3)-β-d-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia

(2013) Yasufumi Matsumura et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Single-Day Trimethoprim/Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia in Children with Cancer

(2013) Désirée Caselli et al.   JOURNAL OF PEDIATRICS

Post-transplant Pneumocystis jirovecii pneumonia—a re-emerged public health problem?

(2013) Jeremy R. Chapman et al.   KIDNEY INTERNATIONAL

Evaluation of PCR in Bronchoalveolar Lavage Fluid for Diagnosis of Pneumocystis jirovecii Pneumonia: A Bivariate Meta-Analysis and Systematic Review

(2013) Li-Chao Fan et al.   PLoS One

Thoracic Infections in Immunocompromised Patients

(2013) Jitesh Ahuja et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

Colonization by Pneumocystis jirovecii and Its Role in Disease

(2012) A. Morris et al.   CLINICAL MICROBIOLOGY REVIEWS

Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies

(2012) Sadatomo Tasaka et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem

(2012) P. V. Coyle et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Pneumocystis Pneumonia

(2011) Shelley Gilroy et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

(2010) A Fontanet et al.   BONE MARROW TRANSPLANTATION

Regionally limited or rare infections: prevention after hematopoietic cell transplantation

(2009) J Gea-Banacloche et al.   BONE MARROW TRANSPLANTATION

Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: Are there any?

(2008) Mayur Ramesh et al.   PEDIATRIC TRANSPLANTATION

No occurrence ofPneumocystis jiroveci (carinii)pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation

(2008) A. Tomonari et al.   Transplant Infectious Disease

Intravenous pentamidine is effective as second linePneumocystis pneumonia prophylaxis in pediatric oncology patients

(2007) Su Young Kim et al.   PEDIATRIC BLOOD & CANCER